\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes AI Continent CybersecurityThe European Commission has made changes to the budget table for calls DIGITAL-2022-CLOUD-AI-03 (deadline 24 January 2023) and DIGITAL-ECCC-2022-CYBER-03 (deadline 15 February 2023):
The budget table relating to this call has been modified ONLY for those topics where the cost category of Financial support to third parties is not an eligible cost.
Please make sure to check the call document to see whether this cost category is eligible under your topic or not. Those topics for which “Financial support to third parties” is not an eligible cost are affected by the removal of the column relating to this cost category in the budget table. Should your topic not allow for this cost category (as per call document), and should you have included an amount under this column, we would recommend that you revise your budget table.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
